H. Khiri

Y. Sterkers, P. Cacoub, P. Halfon, 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Semen May Harbor HIV Despite Effective HAART: Another Piece in the Puzzle

P. Halfon, G. Pénaranda, H. Khiri, 2010, PloS one.

Semen may harbor HIV despite effective HAART: another piece in the puzzle

P. Halfon, G. Pénaranda, H. Khiri, 2010, Retrovirology.

Evaluation of the clinical performance of the Abbott RealTime High-Risk HPV for carcinogenic HPV detection.

A. Agostini, P. Halfon, G. Pénaranda, 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Myasthenia gravis and hepatitis C virus infection

J. Pouget, P. Halfon, M. Bourlière, 1996, Journal of viral hepatitis.

Nationwide large survey on hepatitis B surface antigen quantification use in real-life clinical practice

P. Halfon, G. Pénaranda, H. Khiri, 2015, European journal of gastroenterology & hepatology.

HPV genotype distribution according to severity of cervical neoplasia using the digene HPV genotyping LQ test

A. Raimondo, M. Sideri, P. Halfon, 2013, Archives of Virology.

Phylogenetic analysis of isolated HCV strains from tunisian hemodialysis patients.

L. Bouslama, H. Khiri, Y. Gorgi, 2013, Viral immunology.

Medically assisted procreation and transmission of hepatitis C virus: absence of HCV RNA in purified sperm fraction in HIV co-infected patients

P. Halfon, M. Bourlière, G. Pénaranda, 2006, AIDS.

Mutation rate in hepatitis C virus NS3 protease is not influenced by HIV-1 protease inhibitor therapy.

J. Courcambeck, P. Halfon, M. Bourlière, 2008, AIDS.

Mother-to-infant transmission of hepatitis C virus: molecular evidence of superinfection by homologous virus in children.

J. Sarles, Y. Quentin, P. Halfon, 1999, Journal of hepatology.

Algorithm based on CMV kinetics DNA viral load for preemptive therapy initiation after hematopoietic cell transplantation

P. Halfon, G. Pénaranda, H. Khiri, 2011, Journal of medical virology.

Unusual Selection of Rta181V Hbv Mutants Cross-Resistant to Adefovir following Prolonged Lamivudine Monotherapy: Report of Two Cases

P. Colson, C. Tamalet, D. Botta, 2005, Antiviral therapy.

Dried Blood Spot Sampling for Hepatitis B Virus Serology and Molecular Testing

D. Olive, D. Ouzan, A. Raimondo, 2013, PloS one.

Kinetics of hepatitis C virus RNA load during pegylated interferon alpha-2a and ribavirin treatment in naïve genotype 1 patients

D. Ouzan, P. Halfon, G. Pénaranda, 2005, Comparative hepatology.

Add-on peg-interferon leads to loss of HBsAg in patients with HBeAg-negative chronic hepatitis and HBV DNA fully suppressed by long-term nucleotide analogs.

D. Ouzan, P. Halfon, G. Pénaranda, 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Epidemiological changes in hepatitis C virus genotypes in France: evidence in intravenous drug users

C. Boustière, P. Halfon, M. Bourlière, 2002, Journal of viral hepatitis.

Hepatitis C virus genotypes in chronic hepatitis and response to interferon-alpha therapy.

P. Reynier, P. Halfon, M. Bourlière, 1993, The Journal of infectious diseases.

Covert transmission of hepatitis C virus during bloody fisticuffs.

Y. Quentin, C. Boustière, P. Halfon, 2000, Gastroenterology.

Assessment of early virological response to antiviral therapy by comparing four assays for HCV RNA quantitation using the international unit standard: Implications for clinical management of patients with chronic hepatitis C virus infection

D. Ouzan, P. Halfon, M. Bourlière, 2006, Journal of medical virology.

Incident HPV 51 Infection After Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine Gardasil/Silgard®

P. Halfon, G. Pénaranda, H. Khiri, 2010, Clinical medicine insights. Case reports.

Comparison of the clinical performance of carcinogenic HPV typing of the Linear Array and Papillocheck HPV-screening assay.

P. Halfon, G. Pénaranda, H. Khiri, 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Comparison of ultra-deep versus Sanger sequencing detection of minority mutations on the HIV-1 drug resistance interpretations after virological failure

Ronan Boulmé, Dimitri Gonzalez, Daniel Olive, 2014, AIDS.

Retreatment with direct-acting antivirals of genotypes 1-3-4 hepatitis C patients who failed an anti-NS5A regimen in real world.

V. de Lédinghen, F. Zoulim, D. Ouzan, 2017, Journal of hepatology.

Prevalence of transmitted transfusion virus (TTV) in populations at different risk for hepatitis virus: hemodialysis, chronic hepatitis C and cryptogenetic hepatitis patients.

D. Ouzan, P. Halfon, M. Bourlière, 1999, Journal of hepatology.

Analytical comparison of the cobas HPV Test with Hybrid Capture 2 for the detection of high-risk HPV genotypes.

M. Sideri, P. Halfon, H. Khiri, 2012, The Journal of molecular diagnostics : JMD.

Relevance of HPV mRNA detection in a population of ASCUS plus women using the NucliSENS EasyQ HPV assay.

A. Agostini, P. Halfon, G. Pénaranda, 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Kinetics of disappearance of resistance mutations and reappearance of wild‐type during structured treatment interruptions

P. Clevenbergh, P. Halfon, H. Khiri, 2003, AIDS.

Hepatitis C Virus Genotyping Based on 5′ Noncoding Sequence Analysis (Trugene)

V. de Lédinghen, P. Couzigou, D. Ouzan, 2001, Journal of Clinical Microbiology.

Noncoding Sequence Analysis ( Trugene ) ′ Hepatitis C Virus Genotyping Based on 5

P. Couzigou, D. Ouzan, H. Fleury, 2001 .

Transmission of hepatitis G virus in HCV-infected couples: myth or reality?

D. Ouzan, P. Halfon, M. Bourlière, 1997, Journal of hepatology.

Evaluation of the VERSANT HCV RNA 3.0 Assay for Quantification of Hepatitis C Virus RNA in Serum

H. Fleury, G. Chêne, P. Trimoulet, 2002, Journal of Clinical Microbiology.

Clinical and analytical relevance of NNRTIs minority mutations on viral failure in HIV‐1 infected patients

D. Olive, P. Halfon, H. Khiri, 2014, Journal of medical virology.

Myasthenia gravis and hepatitis C virus infection

J. Pouget, P. Halfon, M. Bourlière, 1995, Journal of viral hepatitis.

Methylenetetrahydrofolate reductase 677 T allele protects against persistent HBV infection in West Africa.

L. Peyrin-Biroulet, A. L. Le Faou, P. Halfon, 2008, Journal of hepatology.

Cloning and initial characterization of human and mouse Spot 14 genes 1

P. Reynier, A. Dace, H. Khiri, 1997, FEBS letters.

Stepwise algorithm combining HPV high-risk DNA-based assays and RNA-based assay for high grade CIN in women with abnormal smears referred to colposcopy.

A. Agostini, P. Halfon, G. Pénaranda, 2011, Cancer biomarkers : section A of Disease markers.

An optimized stepwise algorithm combining rapid antigen and RT-qPCR for screening of COVID-19 patients

F. Retornaz, C. Charpin, P. Halfon, 2021, medRxiv.

Acceptability and efficacy of vaginal self-sampling for genital infection and bacterial vaginosis: A cross-sectional study

L. Chiche, P. Halfon, G. Pénaranda, 2021, PloS one.

[Risk of transmission of hepatitis C virus by digestive endoscopy].

J. Rey, D. Ouzan, P. Halfon, 1995, Gastroenterologie clinique et biologique.

[Cytological and virological medium performance and stability assessment using the Cobas 4800 HPV test (Roche Diagnostics) used in France].

S. Boyer, P. Halfon, G. Pénaranda, 2014, Annales de biologie clinique.

Prospective Evaluation of the Hybrid Capture 2 and AMPLICOR Human Papillomavirus (HPV) Tests for Detection of 13 High-Risk HPV Genotypes in Atypical Squamous Cells of Uncertain Significance

P. Halfon, G. Pénaranda, H. Khiri, 2006, Journal of Clinical Microbiology.

Potential adverse effects of structured therapeutic interruptions on the pool of HIV-infected cells.

P. Halfon, H. Khiri, A. Lafeuillade, 2001, Journal of acquired immune deficiency syndromes.

Assessment of Spontaneous Fluctuations of Viral Load in Untreated Patients with Chronic Hepatitis C by Two Standardized Quantitation Methods: Branched DNA and Amplicor Monitor

P. Halfon, M. Bourlière, H. Khiri, 1998, Journal of Clinical Microbiology.

Methods : Branched DNA and Amplicor Monitor Hepatitis C by Two Standardized Quantitation Viral Load in Untreated Patients with Chronic Assessment of Spontaneous Fluctuations of

P. Halfon, M. Bourlière, H. Khiri, 1998 .

Quantification of HPV16 E6/E7 mRNA Spliced Isoforms Viral Load as a Novel Diagnostic Tool for Improving Cervical Cancer Screening

V. Giordanengo, P. Halfon, G. Pénaranda, 2018, Journal of clinical medicine.

High prevalence of hepatitis E virus antibody in haemodialysis patients

D. Ouzan, P. Halfon, H. Khiri, 1994, The Lancet.

Clinical impact of ultra deep versus Sanger sequencing detection of minority mutations on HIV-1 drug resistance genotype interpretation after virological failure

D. Olive, P. Halfon, G. Pénaranda, 2014, BMC Infectious Diseases.

Prevalence and Characterization of NS5A Resistance Associated Variants in Patients who Relapsed following Exposure to NS5A Inhibitors

F. Zoulim, D. Ouzan, C. Scholtès, 2016 .

Serological response to infection with different isolates of hepatitis C virus.

D. Ouzan, P. Halfon, H. Khiri, 2002, Journal of Viral Hepatitis.

Serotyping and genotyping of hepatitis C virus (HCV) strains in chronic HCV infection

D. Ouzan, P. Halfon, H. Khiri, 1997, Journal of medical virology.

Serological response to infection with different isolates of hepatitis C virus

D. Ouzan, P. Halfon, M. Bourlière, 2002 .

Spontaneous fluctuations of viral load in untreated patients with chronic hepatitis C

P. Halfon, H. Khiri, I. Portal, 1995 .

Quantitative multistandard RT-PCR assay using interspecies polymorphism.

P. Reynier, H. Khiri, R. Planells, 1996, Molecular and cellular probes.

Long-term persistence of HIV with drug resistance after CD4 cell count-guided structured treatment interruption.

P. Halfon, G. Pénaranda, H. Khiri, 2005, AIDS (London).

Occult Hepatitis C Virus Infection Revisited with Ultrasensitive Real-Time PCR Assay

D. Ouzan, D. Sène, P. Cacoub, 2008, Journal of Clinical Microbiology.

Quantification of genotype 4 serum samples: Impact of hepatitis C virus genetic variability

P. Marcellin, P. Halfon, H. Khiri, 2010, Hepatology.

Comparison of the performance of carcinogenic HPV typing of the Roche Linear Array and Qiagen LiquiChip® HPV assays

A. Raimondo, M. Sideri, P. Halfon, 2013, BMC Infectious Diseases.

Persistence of HIV-1 resistance in lymph node mononuclear cell RNA despite effective HAART

P. Halfon, H. Khiri, A Lafeuillade, 2001, AIDS.

Impact of immune interventions on proviral HIV‐1 DNA decay in patients receiving highly active antiretroviral therapy

P. Halfon, H. Khiri, A. Lafeuillade, 2001, HIV medicine.